Reuters logo
11 天内
BRIEF-Aduro Biotech reports $2 mln milestone payment under licensing deal with Merck
2017年7月13日 / 中午12点29分 / 11 天内

BRIEF-Aduro Biotech reports $2 mln milestone payment under licensing deal with Merck

1 分钟阅读

July 13 (Reuters) - Aduro Biotech Inc:‍​

* Aduro Biotech- $2.0 million milestone payment under worldwide licensing deal with merck for work supporting preparation of ind for anti-cd27 antibody​

* ‍Aduro announces milestone achieved relating to collaboration with merck for development of anti-cd27 antibody for treatment of cancer​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below